Market Overview:
The global infertility testing and treatment market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of infertility, rising awareness about fertility treatments, and technological advancements in the field of infertility diagnosis and treatment. The global infertility testing and treatment market can be segmented by type, application, and region. By type, the market can be divided into female infertility testing and male infertility testing. Female Infertility Testing dominates the global market due to high prevalence rates across all regions studied in this research study followed by Male Infertility Testing .By application , Hospitals account for majority share in terms of revenue as compared to Clinics Fertility Centers Research Institutes other segments .
Product Definition:
Infertility testing and treatment refers to the diagnostic tests and procedures that are used to assess fertility and determine the best course of treatment for infertility. Infertility is a condition in which a couple is unable to conceive a child after trying unprotected intercourse for one year. There are many potential causes of infertility, so it is important to undergo testing in order to determine the root cause. Testing can include both physical exams and laboratory tests, such as semen analysis or ovarian function testing. Treatment for infertility may include medications, surgery, or assisted reproductive technologies such as in vitro fertilization (IVF).
Female Infertility Testing:
Introduction: The global female infertility testing, its usage and growth factor in infertility testing and treatment market is expected to witness significant growth over the forecast period. Infertility is a condition where a man and woman are not capable to have children. There are various reasons for this such as stress, lifestyle changes, drug & alcohol abuse, smoking etc., which can reduce the quality of sperm count and increase chances of abnormal sperm morphology (size).
Male Infertility Testing:
Male infertility is the inability of a man to produce sperm which can lead to fertility issues. There are various factors that can cause male infertility such as stress, drugs, alcohol consumption, unhealthy lifestyle and genetic disorders among others. The most common cause of male infertility is a blockage in the vas deferens (the tube that carries sperm from the testicles) caused due to too much weight gain or obesity which leads to lower levels of testosterone production by the body.
Application Insights:
Based on application, the global market is segmented into hospitals, clinics, fertility centers and research institutes. Hospitals held the largest share in 2017 owing to rising prevalence of chronic conditions such as polycystic ovary syndrome (PCOS) and male factor infertility. PCOS is a common disorder among women and accounts for approximately 10% of all female infertility cases. According to data published by WHO in 2018, around 40 million women are affected by this condition worldwide.
The other segment¢â‚¬â„¢s share is expected to witness the highest growth during forecast years due to increasing number of patients seeking treatment for Infertility issues across the globe. Increasing awareness about available treatments along with rising R&D activities pertaining to diagnosis & treatment of infertile couples are some factors anticipated drive market growth over next few years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of fertility clinics and hospitals, supportive government initiatives, and high healthcare expenditure in this region. For instance, as reported by Fertility Today’s issue in August 2018, there are over 1 million women suffering from infertility problems in the U.S., which is around 4% of all female population aged 15 to 44 years. Thus, it is one of the leading causes for concern among American couples trying to have children or facing difficulty having kids at all.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing awareness about available treatment options for various fertility disorders coupled with rising medical tourism due to affordability issues associated with treatments offered within India and China (even though these countries offer world-class services). The availability of technologically advanced treatment procedures at low cost compared with developed nations will continue driving demand across this region during forecast period as well as future editions.
Growth Factors:
- Increasing incidence of infertility: The global infertility rate is estimated to be around 10-15%. This number is only going to increase in the years to come, due to increasing stress levels, changing lifestyles and environmental factors. This will create a large pool of potential patients for fertility testing and treatment services.
- Growing awareness about fertility issues: There is a growing awareness among people about the various causes and treatments of infertility. This has led to an increase in the demand for fertility testing and treatment services worldwide.
- Advances in reproductive technologies: The field of reproductive medicine is constantly evolving, with new technologies being developed every day. This has resulted in improved success rates for fertility treatments, thus driving demand for these services further up.
Scope Of The Report
Report Attributes
Report Details
Report Title
INFERTILITY TESTING AND TREATMENT Market Research Report
By Type
Female Infertility Testing, Male Infertility Testing
By Application
Hospitals, Clinics, Fertility Centers, Research Institutes, Other
By Companies
Merck, Procter & Gamble, BioMerieux, Abbott, Babystart, BioZhena Corporation, Quidel Corporation, SPD Swiss Precision Diagnostics, SCSA Diagnostics, Pride Angel
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
193
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global INFERTILITY TESTING AND TREATMENT Market Report Segments:
The global INFERTILITY TESTING AND TREATMENT market is segmented on the basis of:
Types
Female Infertility Testing, Male Infertility Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Fertility Centers, Research Institutes, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Procter & Gamble
- BioMerieux
- Abbott
- Babystart
- BioZhena Corporation
- Quidel Corporation
- SPD Swiss Precision Diagnostics
- SCSA Diagnostics
- Pride Angel
Highlights of The INFERTILITY TESTING AND TREATMENT Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Female Infertility Testing
- Male Infertility Testing
- By Application:
- Hospitals
- Clinics
- Fertility Centers
- Research Institutes
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the INFERTILITY TESTING AND TREATMENT Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In vitro fertilization (IVF) is a process by which eggs are retrieved from a womanu2019s ovaries and then fertilized with sperm outside the body. The resulting embryos are then transferred back into the womanu2019s uterus for continued development. If successful, IVF can result in the birth of a baby.nnThere are many different types of infertility treatments available, but they all share one goal: to help couples conceive children who may not be able to do so naturally. Some common treatments include:
Some of the key players operating in the infertility testing and treatment market are Merck, Procter & Gamble, BioMerieux, Abbott, Babystart, BioZhena Corporation, Quidel Corporation, SPD Swiss Precision Diagnostics, SCSA Diagnostics, Pride Angel.
The infertility testing and treatment market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 INFERTILITY TESTING AND TREATMENT Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 INFERTILITY TESTING AND TREATMENT Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 INFERTILITY TESTING AND TREATMENT Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the INFERTILITY TESTING AND TREATMENT Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global INFERTILITY TESTING AND TREATMENT Market Size & Forecast, 2018-2028
4.5.1 INFERTILITY TESTING AND TREATMENT Market Size and Y-o-Y Growth
4.5.2 INFERTILITY TESTING AND TREATMENT Market Absolute $ Opportunity
Chapter 5 Global INFERTILITY TESTING AND TREATMENT Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 INFERTILITY TESTING AND TREATMENT Market Size Forecast by Type
5.2.1 Female Infertility Testing
5.2.2 Male Infertility Testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global INFERTILITY TESTING AND TREATMENT Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 INFERTILITY TESTING AND TREATMENT Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Fertility Centers
6.2.4 Research Institutes
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global INFERTILITY TESTING AND TREATMENT Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 INFERTILITY TESTING AND TREATMENT Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America INFERTILITY TESTING AND TREATMENT Analysis and Forecast
9.1 Introduction
9.2 North America INFERTILITY TESTING AND TREATMENT Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America INFERTILITY TESTING AND TREATMENT Market Size Forecast by Type
9.6.1 Female Infertility Testing
9.6.2 Male Infertility Testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America INFERTILITY TESTING AND TREATMENT Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Fertility Centers
9.10.4 Research Institutes
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe INFERTILITY TESTING AND TREATMENT Analysis and Forecast
10.1 Introduction
10.2 Europe INFERTILITY TESTING AND TREATMENT Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe INFERTILITY TESTING AND TREATMENT Market Size Forecast by Type
10.6.1 Female Infertility Testing
10.6.2 Male Infertility Testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe INFERTILITY TESTING AND TREATMENT Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Fertility Centers
10.10.4 Research Institutes
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific INFERTILITY TESTING AND TREATMENT Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific INFERTILITY TESTING AND TREATMENT Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific INFERTILITY TESTING AND TREATMENT Market Size Forecast by Type
11.6.1 Female Infertility Testing
11.6.2 Male Infertility Testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific INFERTILITY TESTING AND TREATMENT Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Fertility Centers
11.10.4 Research Institutes
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America INFERTILITY TESTING AND TREATMENT Analysis and Forecast
12.1 Introduction
12.2 Latin America INFERTILITY TESTING AND TREATMENT Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America INFERTILITY TESTING AND TREATMENT Market Size Forecast by Type
12.6.1 Female Infertility Testing
12.6.2 Male Infertility Testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America INFERTILITY TESTING AND TREATMENT Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Fertility Centers
12.10.4 Research Institutes
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) INFERTILITY TESTING AND TREATMENT Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) INFERTILITY TESTING AND TREATMENT Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) INFERTILITY TESTING AND TREATMENT Market Size Forecast by Type
13.6.1 Female Infertility Testing
13.6.2 Male Infertility Testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) INFERTILITY TESTING AND TREATMENT Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Fertility Centers
13.10.4 Research Institutes
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 INFERTILITY TESTING AND TREATMENT Market: Competitive Dashboard
14.2 Global INFERTILITY TESTING AND TREATMENT Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Procter & Gamble
14.3.3 BioMerieux
14.3.4 Abbott
14.3.5 Babystart
14.3.6 BioZhena Corporation
14.3.7 Quidel Corporation
14.3.8 SPD Swiss Precision Diagnostics
14.3.9 SCSA Diagnostics
14.3.10 Pride Angel
